Fred Guerard

Fred Guerard is the current Director at Lenz Therapeutics. Prior to this, they held various positions at different companies including Graybug Vision, Inc., Alcon, a Novartis company, The Association of the British Pharmaceutical Industry (ABPI), and Medicines Australia. At Novartis, they were the Worldwide Business Franchise head Ophthalmology where they lead the $5.3 billion, 6,000-associate, Ophthalmology franchise which holds the #1 position globally across 125 countries and serves ~200 million patients per year. Fred was also the Managing Director - UK and Ireland at Novartis from April 1999 to April 2015.

Fred Guerard's educational career includes completing an executive education at Harvard School of Public Health, as well as executive education programs in leadership and finance at Harvard Business School. Fred also holds masters degrees in marketing from HEC Paris, and medical and biological sciences from Université de Rouen. Fred's doctorate is in pharmacy from Université de Rouen.